Also found in: Thesaurus, Medical, Wikipedia.


A trademark for the sulfate form of the drug tranylcypromine.
References in periodicals archive ?
Tranylcypromine, marketed since the 1960s as Parnate, Inhibited initial herpes infection in animal tests, reduced flare-ups in previously infected animals and rendered them less infectious to others, researchers report in the Dec.
rights for Fortaz (ceftazidime), Zinacef (cefuroxime), Lanoxin (digoxin), Parnate (tranylcypromine sulfate) and Zantac Injection (ranitidine hydrochloride) from GlaxoSmithKline PLC (GSK).
22 December 2011 - Swiss Covis Pharma Sarl said today it had agreed to acquire the US and Puerto Rican rights from UK GlaxoSmithKline (LON:GSK) to Fortaz (ceftazidime), Zinacef (cefuroxime), Lanoxin (digoxin), Parnate (tranylcypromine sulfate), and Zantac Injection (ranitidine hydrochloride).